| abstract |
Provided is a material that, as a myocardial/cardiovascular regeneration device, is for the treatment of advanced heart failure, and with respect to the fundamental treatment of intractable circulatory diseases regarding which not only saving lives but also improving quality of life (QOL) are pressing issues, particularly advanced heart failure, has a high treatment effect, and by means of commercialization rendering unnecessary (cell-free) the culturing of cells by performing stem cell control, has increased universality and is self-assembled in a manner capable of emergency use. The advanced heart failure treatment material is provided with a drug, a drug holding agent, and a myocardial support device. |